Fundraising Fox

Sophiris BIO

La Jolla, US · British Columbia, Canada corporation · 1 known investors

Biotech

Founders & leadership

AE
Allison E. HulmeExecutive
RE
Randall E. WoodsExecutive
PT
Peter T. SloverExecutive
GT
Gerald T ProehlNamed on SEC filing
JE
John E GeltoskyNamed on SEC filing
JE
Jim E. HeppellNamed on SEC filing

Board

LELars Ekman
Lars EkmaninBoard directorExecutive Partner, Private Equity at Sofinnova Ventures

Investors · 1

Sofinnova VenturesMenlo Park · $100K – $15M

Reported raises · per SEC filings

Form D private placements

$5.1M disclosed across 1 round · 2019

▶$5.1MraisedSep 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gerald T ProehlDirector
  • Lars EkmanDirector
  • Allison E. HulmeExecutive Officer, Director
  • Randall E. WoodsExecutive Officer, Director
  • John E GeltoskyDirector
  • Peter T. SloverExecutive Officer
  • Jim E. HeppellDirector
Offering amount
$5.1M
Amount sold
$5.1M
Sales commissions
$240K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Aug 2019
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Sophiris BIO's investors?
Sophiris BIO's investors include Sofinnova Ventures.
How much funding has Sophiris BIO raised?
Sophiris BIO has disclosed $5.1M raised across 1 round.
Where is Sophiris BIO headquartered?
Sophiris BIO is headquartered in La Jolla, US.